Regulatory monitoring

ATESSIA is pleased to announce the publication of the new Atessia Journal fully dedicated to the reform of early access and compassionate access. Atessia wished to bring you its expertise by proposing its analysis on the early access reform now applicable since July 1st 2021, a reform which metamorphoses its system for industrials, health professionals and patients.

You will also find a retrospective of the news published on Atessia Intelligence on this subject between 2020 and 2021.

This Atessia Journal is available for free with a subscription to Atessia Intelligence!

The new Atessia Intelligence newsletter: Atessia Highlights. Our regulatory intelligence service has been enriched with a new format, which is monthly. This newsletter is sent out at the beginning of each month to find the 10 news items that shouldn’t be missed! This deliverable is included in all subscriptions!

ATESSIA is pleased to announce the publication of the new Atessia Journal fully dedicated to biosimilar medicines. Atessia wanted to bring you its expertise by offering you its analysis of the French market and regulations regarding biosimilar drugs.

You will also find a retrospective of the news published on Atessia Intelligence on this subject between 2019 and 2020.

This Atessia Journal is available for free with a subscription to Atessia Intelligence!

Atessia Intelligence, the regulatory monitoring service has reached 80 subscribers! Our regulatory intelligence service is available by subscription! We adapt to your needs with 3 subscription formulas and options to complete your formula. Contact us at hello@atessia.fr

Many thanks to all of you for following us!

ATESSIA is pleased to announce the publication of the new Atessia Journal fully dedicated to inspections. Atessia, thanks to its expertise, has analysed for you the results of ANSM inspections over the last 24 months.

It is available for download from your ATESSIA INTELLIGENCE account in the Atessia Journal section!